These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 8438362

  • 1. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
    Hasan RI, Sriwatanawongsa V, Wallwork J, White DJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):421-2. PubMed ID: 8438362
    [No Abstract] [Full Text] [Related]

  • 2. Graft adaptation in hamster-to-rat cardiac xenografts.
    Hasan RI, Sriwatanawangosa V, Wallwork J, White DJ.
    Transplant Proc; 1994 Jun; 26(3):1282-3. PubMed ID: 8029909
    [No Abstract] [Full Text] [Related]

  • 3. Prolongation of survival of heterotopic heart xenografts by antibody and complement suppression in primates.
    Mieny CJ, Karusseit VO, Van den Bogaerde JB, Hasan RI, White DJ.
    Transplant Proc; 1994 Jun; 26(3):1073. PubMed ID: 8029834
    [No Abstract] [Full Text] [Related]

  • 4. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody.
    Steinbrüchel DA, Madsen HH, Nielsen B, Kemp E, Larsen S, Koch C.
    Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667
    [No Abstract] [Full Text] [Related]

  • 5. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F, Chong A, Foster P, Sankary H, McChesney L, Williams JM, Frieders D, Williams JW.
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract] [Full Text] [Related]

  • 7. Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy.
    Hasan RI, van den Bogaerde J, Forty J, Wright L, Wallwork J, White DJ.
    Transplant Proc; 1992 Apr; 24(2):517-8. PubMed ID: 1566412
    [No Abstract] [Full Text] [Related]

  • 8. Prolonged survival of cardiac xenografts between widely divergent species: bird to mammal.
    Braidley PC, Wallwork J, White DJ.
    Transplant Proc; 1995 Feb; 27(1):307-8. PubMed ID: 7879013
    [No Abstract] [Full Text] [Related]

  • 9. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L.
    J Heart Lung Transplant; 1994 Feb; 13(3):489-97. PubMed ID: 8061026
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA, Lillevang ST, Nielsen B, Kemp E.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract] [Full Text] [Related]

  • 11. Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
    Quarantillo P, Araneda D, Thomas F, Thomas J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):387-8. PubMed ID: 8438347
    [No Abstract] [Full Text] [Related]

  • 12. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
    Lin Y, Vandeputte M, Waer M.
    Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376
    [No Abstract] [Full Text] [Related]

  • 13. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation.
    Thomas F, Araneda D, Quarantillo P.
    Transplant Proc; 1994 Jun; 26(3):1220-3. PubMed ID: 8029894
    [No Abstract] [Full Text] [Related]

  • 14. Prolongation of xenograft survival by exchange transfusions and immunosuppression.
    Bouwman E, de Bruin RW, Jeekel J, Marquet RL.
    Transplant Proc; 1990 Jun; 22(3):1079-80. PubMed ID: 2190374
    [No Abstract] [Full Text] [Related]

  • 15. Survival of hamster heart xenografts in rat recipients on a relatively mild immunosuppressive protocol.
    Scheringa M, Töns A, Bouwman E.
    Transplant Proc; 1996 Apr; 28(2):833-4. PubMed ID: 8623423
    [No Abstract] [Full Text] [Related]

  • 16. Xenogeneic bone marrow transplantation in the hamster-to-rat model prevents rejection of subsequently grafted hamster hearts.
    Bouwman E, Scheringa M, Marquet RL.
    Transplant Proc; 1996 Apr; 28(2):681-2. PubMed ID: 8623342
    [No Abstract] [Full Text] [Related]

  • 17. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of rejection of hamster-to-rat heart xenografts.
    Hasan R, van den Bogaerde J, Forty J, Wright L, Wallwork J, White DJ.
    Transpl Int; 1992 Dec; 5 Suppl 1():S313-7. PubMed ID: 14621810
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation.
    Hayashi S, Ito M, Yokoyama I, Uchida K, Takagi H.
    Transplant Proc; 1994 Jun; 26(3):1284. PubMed ID: 7518126
    [No Abstract] [Full Text] [Related]

  • 20. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS, Shen J, Xiao F, Blinder L, Foster P, Sankary H, Williams JW.
    Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.